Buprenorphine‐naloxone combination appears safe during pregnancy
A cohort study has found comparable neonatal and maternal outcomes for women receiving the combination of buprenorphine and naloxone in the first trimester of pregnancy and women receiving buprenorphine alone. The results suggest that both formulations of buprenorphine appear to be a safe choice for pregnant women with opioid use disorder (OUD).
Publication Details
- Journal
- The Brown University Psychopharmacology Update
- Published
- 2024-11-05
- DOI
- https://doi.org/10.1002/pu.31238
- Primary Topic
- Prenatal Substance Exposure Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00